HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David G Little Selected Research

Legg-Calve-Perthes Disease (Perthes Disease)

1/2016The Pathogenesis and Treatment of Legg-Calvé-Perthes Disease.
7/2014Local delivery of recombinant human bone morphogenetic proteins and bisphosphonate via sucrose acetate isobutyrate can prevent femoral head collapse in Legg-Calve-Perthes disease: a pilot study in pigs.
9/2012Evidence for using bisphosphonate to treat Legg-Calvé-Perthes disease.
9/2011Potential for bisphosphonate treatment in Legg-Calve-Perthes disease.
7/2011Future biologic treatments for Perthes disease.
11/2009Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg-Calve-Perthes disease.
10/2005Transient disturbance in physeal morphology is associated with long-term effects of nitrogen-containing bisphosphonates in growing rabbits.
7/2005Zoledronic acid improves femoral head sphericity in a rat model of perthes disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David G Little Research Topics

Disease

8Bone Resorption
01/2017 - 07/2005
8Legg-Calve-Perthes Disease (Perthes Disease)
01/2016 - 07/2005
8Osteonecrosis (Kienbock's Disease)
04/2015 - 11/2003
6Osteogenesis Imperfecta (Lobstein Disease)
07/2022 - 10/2005
6Open Fractures (Compound Fracture)
07/2022 - 02/2013
6Osteoporosis
11/2011 - 10/2005
5Closed Fractures (Closed Fracture)
01/2020 - 03/2010
5Pseudarthrosis (Pseudoarthrosis)
01/2018 - 01/2008
4Neurofibromatosis 1 (Neurofibromatosis Type I)
10/2021 - 01/2008
4Infections
01/2020 - 02/2015
4Osteolysis
06/2017 - 11/2008
3Wounds and Injuries (Trauma)
01/2018 - 08/2007
3Fibrosis (Cirrhosis)
01/2018 - 04/2013
2Muscle Weakness
10/2021 - 01/2018
2Heterotopic Ossification (Ectopic Ossification)
01/2021 - 07/2014
2Tibial Fractures (Fracture, Tibial)
12/2019 - 01/2018
2Muscular Diseases (Myopathy)
10/2018 - 01/2018
2Body Weight (Weight, Body)
01/2018 - 12/2009
2Femoral Fractures (Femoral Fracture)
01/2018 - 03/2010
2Pain (Aches)
09/2013 - 09/2012
2Congenital Abnormalities (Deformity)
09/2012 - 09/2011
2Coxa Magna
09/2012 - 09/2011
2Metabolic Bone Diseases (Osteopenia)
10/2008 - 07/2003
1Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
07/2022
1Peroneal Neuropathies
07/2022
1Fatigue
10/2021
1Weight Loss (Weight Reduction)
07/2021
1Diastrophic dysplasia
01/2021
1Multiple Acyl Coenzyme A Dehydrogenase Deficiency
10/2018
1Inborn Genetic Diseases (Disease, Hereditary)
10/2018
1Myopathy with Abnormal Lipid Metabolism
01/2018
1Inflammation (Inflammations)
06/2017
1Multiple Myeloma
01/2017
1Slipped Capital Femoral Epiphyses
04/2015
1Staphylococcal Infections
02/2015
1Bone Diseases (Bone Disease)
07/2013
1Bone Fractures (Bone Fracture)
01/2012
1Necrosis
11/2009
1Scoliosis
04/2008
1Acute-Phase Reaction
09/2007
1Osteopetrosis
06/2005

Drug/Important Bio-Agent (IBA)

21Diphosphonates (Bisphosphonates)IBA
01/2020 - 06/2005
13Zoledronic Acid (Zometa)FDA Link
07/2022 - 07/2003
5Pharmaceutical PreparationsIBA
01/2020 - 06/2005
4LipidsIBA
01/2020 - 01/2018
4Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
01/2016 - 01/2008
3Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 02/2015
3CSA-90IBA
01/2020 - 02/2015
3Biological ProductsIBA
01/2016 - 07/2011
32- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2012 - 04/2008
3MineralsIBA
09/2008 - 07/2003
2alpha2 Subunit Collagen Type IIBA
07/2022 - 01/2019
2Pamidronate (Aredia)FDA LinkGeneric
01/2020 - 11/2008
2recombinant human bone morphogenetic protein-2IBA
01/2018 - 02/2015
2CollagenIBA
01/2018 - 01/2016
2Parathyroid Hormone (Parathormone)IBA
02/2016 - 03/2010
2sucrose acetate isobutyrateIBA
01/2016 - 07/2014
2SteroidsIBA
02/2015 - 09/2013
2Bone Density Conservation AgentsIBA
07/2013 - 09/2011
2Anabolic AgentsIBA
09/2012 - 03/2010
1Growth Hormone (Somatotropin)IBA
01/2022
1Carnitine (L-Carnitine)FDA LinkGeneric
10/2021
1Peptides (Polypeptides)IBA
01/2020
1tdTomatoIBA
12/2019
1Collagen Type I (Type I Collagen)IBA
01/2019
1Sirolimus (Rapamycin)FDA Link
01/2019
1oil red OIBA
01/2018
1PeptidomimeticsIBA
01/2018
1mirdametinibIBA
01/2018
1AntibodiesIBA
01/2018
1PolymersIBA
06/2017
1Proteins (Proteins, Gene)FDA Link
01/2017
1ActRIIA-mIgG2aFc fusion proteinIBA
02/2016
1ORALIT (ORS)IBA
04/2015
1artemisinin-naphthoquine combinationIBA
09/2013
1Pain-FreeIBA
09/2013
1PlasticsIBA
04/2013
1Bromodeoxyuridine (BrdU)IBA
01/2012
1Neuropeptide YIBA
12/2009
1Polymethyl Methacrylate (Sol)IBA
11/2008

Therapy/Procedure

8Therapeutics
07/2022 - 08/2007
3Osteotomy
01/2017 - 03/2010
2Arthroplasty
09/2013 - 07/2011
2Distraction Osteogenesis
10/2005 - 07/2003
1Foot Orthoses
07/2022
1Euthanasia (Mercy Killing)
07/2021
1Traction
01/2021
1Injections
12/2019
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2019
1Bone Wires
01/2018
1Decompression
04/2015
1Analgesia
09/2013
1Drug Therapy (Chemotherapy)
09/2013
1Bone Transplantation (Bone Grafting)
07/2011
1Hip Replacement Arthroplasty (Total Hip Replacement)
11/2008
1External Fixators
06/2007